AUS
NZ
UK
CA
USA
IND
Healthcare
Telix Pharmaceuticals (ASX:TLX) Advances Trials in ASX 100
March 23, 2026 03:49 PM AEDT| By SamTelix Pharmaceuticals (ASX:TLX) continues development of TLX101-Px and TLX591-Tx, highlighting regulatory progress and sector significance within the ASX 100.
Is Echo IQ (ASX:EIQ) Entry Reshaping ASX all ords?
March 23, 2026 03:05 PM AEDT| By SamEcho IQ joins the ASX all ords, reflecting increased healthcare technology participation and evolving market composition within Australia’s equity landscape.
Is Amplia Therapeutics (ASX:ATX) Advancing Cancer Trial Progress?
March 23, 2026 01:40 PM AEDT| By SamAmplia Therapeutics advances pancreatic cancer research through clinical trial progress, highlighting healthcare sector activity within the ASX All Ordinaries framework.
Island Pharma Share Move: What It Means Now
March 23, 2026 11:25 AM AEDT| By SamIsland Pharmaceuticals expands its share base through ASX quotation, highlighting capital flexibility and evolving liquidity dynamics within Australia’s healthcare-focused market environment.
ASX Healthcare Faces Pressure as Key Catalysts Drive Focus
March 20, 2026 05:48 PM AEDT| By SamASX healthcare stocks navigate macro pressures as clinical progress, regulatory updates, and innovation-driven milestones guide sector momentum and reshape market attention.
ASX 200 Update: Adherium Expands Through Share Move
March 20, 2026 04:38 PM AEDT| By Team Kalkine MediaAdherium strengthens its capital strategy through new share quotation, reflecting broader trends in healthcare innovation and evolving dynamics within Australia’s equity market.
CSL Limited (ASX:CSL) Expands US Capacity, Signals ASX20 Shift
March 20, 2026 04:36 PM AEDT| By SamCSL growth in the asx 20 reflects large scale manufacturing expansion, improved plasma processing efficiency, and alignment with global biotechnology trends shaping therapy production capacity.
Adherium Share Expansion Update Aligns with ASX 200
March 20, 2026 04:19 PM AEDT| By SamAdherium advances its capital structure with new share quotation activity, aligning with broader healthcare technology trends across the Australian equity market landscape.
Could Argent Biopharma Move Reshape ASX Healthcare Focus?
March 20, 2026 03:59 PM AEDT| By SamArgent Biopharma advances share quotation process, reflecting capital structure activity within ASX All Ords and supporting ongoing pharmaceutical development initiatives.
Is ASX 200 CSL Expansion Reshaping Pharma Sector?
March 20, 2026 01:28 PM AEDT| By SamCSL expands US manufacturing footprint, highlighting pharmaceutical sector activity and its influence across the All Ordinaries and broader market participation.
Vita Resources Advances ICE Project in Yukon
March 20, 2026 12:15 PM AEDT| By SamVita Resources advances its ICE project in Yukon following a key recommendation, highlighting exploration progress within the ASX All Ordinaries mining sector.
Alterity Therapeutics ASX Updates Capital Plan Amid Options Issue Move
March 19, 2026 07:19 PM AEDT| By SamAlterity Therapeutics outlines a structured options issuance plan on the ASX, highlighting its capital framework and role within the biotechnology sector and broader Australian market activity.
Race Oncology Advances in ASX All Ords Healthcare
March 19, 2026 01:56 PM AEDT| By SamRace Oncology (ASX:RAC) highlights biotechnology sector activity within ASX All Ordinaries, focusing on clinical development and healthcare innovation.
Is All Ordinaries Neurizon Expanding Its Share Base?
March 19, 2026 12:22 PM AEDT| By SamNeurizon Therapeutics seeks ASX quotation for new shares, reflecting capital structure updates and healthcare sector activity within the All Ordinaries market framework.
Adherium Share Move Sparks ASX Market Attention
March 19, 2026 11:35 AM AEDT| By SamAdherium’s share quotation expansion highlights liquidity changes, strategic capital alignment, and the growing importance of digital health within Australia’s evolving market environment.
Orthocell Advances Global Reach with Remplir Success
March 19, 2026 06:42 AM AEDT| By SamOrthocell’s Remplir device demonstrates real-world effectiveness in complex surgical cases, supporting global expansion and strengthening its position across advanced medical and defence healthcare markets.
4DMedical Advances Share Quotation Move Amid ASX 200 Focus
March 18, 2026 05:20 PM AEDT| By Sam4DMedical advances its share quotation process, aligning with ASX requirements while reflecting ongoing capital structure updates within the healthcare technology segment.
ASX 300 Nanosonics Unveils New Share Incentive Move
March 18, 2026 03:54 PM AEDT| By SamNanosonics seeks ASX quotation for employee incentive shares, reflecting equity structure updates and governance activity within the ASX 300 healthcare technology sector.
Healthcare Sector Activity Across the ASX Market
March 18, 2026 02:10 PM AEDT| By SamCann Group progresses ASX share quotation plans, highlighting capital market activity within the healthcare sector and its role across the All Ordinaries index.
Can Sofdra Drive a Turnaround for ASX Healthcare Stock?
March 18, 2026 12:42 PM AEDT| By SamBotanix Pharmaceuticals faces a defining phase as Sofdra adoption, cost control, and platform strength determine whether its commercial strategy can stabilise momentum in a competitive healthcare landscape.
Advertise your brand on Kalkine Media